Amanda Eustace

发表

Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer

A. Harris, H. Denley, P. Hoskin, 2016, British Journal of Cancer.

Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer

H. Denley, P. Hoskin, C. West, 2014, British Journal of Cancer.

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial

A. Harris, H. Denley, P. Hoskin, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma.

Crispin J. Miller, A. Harris, C. Möller-Levet, 2013, European journal of cancer.

A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients

Ananya Choudhury, Jan Alsner, Catharine M L West, 2017, Clinical Cancer Research.

A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer

Crispin J. Miller, A. Harris, P. Span, 2013, Clinical Cancer Research.

Cancer Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder A 26-Gene Hypoxia Signature Predicts Benefit from

Crispin J. Miller, A. Harris, P. Span, 2013 .

Predictive Biomarkers and Personalized Medicine A 26-Gene Hypoxia Signature Predicts Bene fi t fromHypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer

Crispin J. Miller, A. Harris, P. Span, 2013 .

Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells

I. Stratford, M. Tilby, K. Williams, 2009, British Journal of Cancer.

Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas

G. Brabant, B. Telfer, C. West, 2016, Oncotarget.

Identification of cells expressing IL-17A and IL-17F in the lungs of patients with COPD.

Dave Singh, A. Eustace, J. Plumb, 2011, Chest.

Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation

Crispin J. Miller, P. Hoskin, C. West, 2012, British Journal of Cancer.

Role of T Regulatory Cells in the Pathogenesis of Asthma: Response

Dave Singh, U. Kolsum, A. Eustace, 2010 .

Reversing Hypoxic Cell Chemoresistance in Vitro Using Genetic and Small Molecule Approaches Targeting Hypoxia Inducible Factor-1

J. Erler, I. Stratford, K. Williams, 2006, Molecular Pharmacology.

Lysyl oxidase: from basic science to future cancer treatment.

C. West, T. Nishioka, A. Eustace, 2012, Cell structure and function.

Increased airway T regulatory cells in asthmatic subjects.

Dave Singh, U. Kolsum, A. Eustace, 2010, Chest.

FTIR microspectroscopy of selected rare diverse sub‐variants of carcinoma of the urinary bladder

H. Denley, N. Clarke, P. Hoskin, 2013, Journal of biophotonics.